Keyphrases
Cisplatin
100%
Vinblastine
100%
Cisplatin-based Chemotherapy
100%
Doxorubicin Treatments
100%
Transitional Cell Carcinoma of the Urothelium
100%
Methotrexate Chemotherapy
100%
Doxorubicin
87%
Methotrexate
87%
Neoadjuvant Setting
37%
Transitional Cell Carcinoma
25%
Blood Count
25%
Neoadjuvant Chemotherapy
25%
Serum Creatinine
25%
Histological Grade
25%
Relative Dose Intensity
25%
Tumor
12%
Treatment-related Mortality
12%
Partial Response
12%
Number of Cycles
12%
Vomiting
12%
Receptor Antagonist
12%
Am(III)
12%
Chemotherapy
12%
Chemotherapy Regimen
12%
Complete Response
12%
Stable Disease
12%
Creatinine Clearance
12%
Severe Toxicity
12%
Neutropenia
12%
Metastatic Disease
12%
Partial Cystectomy
12%
Radical Cystectomy
12%
Median Survival
12%
Urinary Bladder
12%
Response Assessment
12%
Transurethral Resection of Bladder Tumor (TURBT)
12%
Urothelium
12%
Mucositis
12%
Metastatic Setting
12%
Bladder Preserving
12%
Medicine and Dentistry
Methotrexate
100%
Cisplatin
100%
Transitional Cell Carcinoma
100%
Doxorubicin
100%
Vinblastine
100%
Urothelium
100%
Disease
44%
Bladder
22%
Creatinine
22%
Cystectomy
22%
Neoadjuvant Chemotherapy
22%
Neoplasm
11%
Receptor Antagonist
11%
Side Effect
11%
Chemotherapy Regimens
11%
Metastatic Carcinoma
11%
Creatinine Clearance
11%
Neutropenia
11%
Furosemide
11%
Transurethral Resection
11%
Serotonin
11%
Mucositis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Cisplatin
100%
Chemotherapy
100%
Methotrexate
100%
Transitional Cell Carcinoma
100%
Vinblastine
100%
Disease
44%
Creatinine
33%
Furosemide
11%
Neoplasm
11%
Metastasis
11%
Side Effect
11%
Neutropenia
11%
Hydration
11%
Serotonin
11%
Chemotherapy Regimens
11%
Receptor Antagonist
11%
Mucosa Inflammation
11%